Grant & Eisenhofer PA said it is representing a whistleblower in a false claims lawsuit unsealed Thursday against Celgene Corp., of Summit, N.J., alleging off-label marketing of Thalomid (thalidomide) and Revlimid (lenalidomide) to cancer patients and payment of kickbacks to physicians for prescribing the medications.